Acquisition Opportunity Cambium Analytica was acquired by NSF in October 2025, signaling a strategic expansion into analytical testing and development for natural products under a larger health and safety-focused organization. This presents a cross-sell or up-sell opportunity to NSF’s existing clients in public health and safety sectors seeking enhanced laboratory capabilities and product development support for natural foods, dietary supplements, botanicals, and natural pharmaceuticals.

Natural Product Focus Specialization in natural foods, dietary supplements, botanical products, and natural pharmaceuticals indicates a strong alignment with fast-growing sectors prioritizing quality assurance, regulatory compliance, and complex analytical testing. Sales prospects include contract testing, method development, and product characterization for nutraceutical brands, functional foods, and plant-based pharmaceuticals.

Financial Capacity Reported revenue in the mid tens of millions range combined with a mid-sized employee base suggests substantial project capacity and the ability to take on sizable testing and development engagements. This supports targeting mid-market biotechs and consumer health brands seeking robust analytical partners with scalable resources.

Digital & Cloud Readiness Deployment of AWS, Google Workspace, HubSpot Analytics, Webflow, Squarespace and other modern SaaS tools demonstrates a tech-forward operation with strong data handling, collaboration, and customer relationship management capabilities. This enables offering integrated digital services, data-driven reporting, and scalable collaboration for clients with global or multi-site needs.

Growth Through Collaboration Recent acquisition by a global public health organization combined with existing capabilities positions Cambium Analytica as a gateway for partnerships in quality assurance, regulatory support, and product development for natural product brands. Target alliances with dietary supplement manufacturers, natural product startups, and regulatory-focused firms seeking enhanced testing, method development, and compliance services.